Bristol-Myers Squibb Co. has completed its acquisition of Celgene Corp. following the receipt of regulatory approval from all government authorities required by the merger agreement and, as announced on April 12, approval by Bristol-Myers Squibb and Celgene stockholders. It completed the acquisition Nov. 20.
The NCI Human Tumor Atlas Network (HTAN) has published a cluster of papers intended to advance the framework of spatial omics, the science of profiling morphological and molecular features of human cancers in two and three dimensions.
